Pulse Biosciences (PLSE) Debt Ratio (2021 - 2023)
Pulse Biosciences (PLSE) posted quarterly Debt Ratio of 0.93 for Q1 2023, up 10.9% quarter-over-quarter from 0.83 in Q4 2022.
Pulse Biosciences (PLSE) Debt Ratio (2021 - 2023) Analysis & Trends
Pulse Biosciences' Debt Ratio history runs 3 years deep, the most recent figure standing at 0.93 for Q1 2023.
- In Q1 2023, Debt Ratio changed N/A year-over-year to 0.93; the TTM figure through Mar 2023 stood at 0.93 (changed N/A YoY), while the FY2022 annual figure was 0.83, changed N/A from the prior year.
- Debt Ratio for Q1 2023 stood at 0.93, up from 0.83 in the prior quarter.
- The five-year high for Debt Ratio was 0.93 in Q1 2023, with the low at 0.51 in Q1 2021.
- The 3-year median for Debt Ratio is 0.79 (2022), against an average of 0.75.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 133.72 Bn | 128.51 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.22 Bn | 51.35 Bn | 2.32 Bn | 0.33 |
| 3 | Alcon | 35.68 Bn | 34.32 Bn | 1.68 Bn | 0.15 |
| 4 | Resmed | 33.70 Bn | 32.23 Bn | 861.22 Mn | 0.07 |
| 5 | Medline | 28.68 Bn | 26.01 Bn | 2.22 Bn | 0.32 |
| 6 | West Pharmaceutical Services | 24.95 Bn | 24.51 Bn | 329.20 Mn | 0.05 |
| 7 | Solventum | 15.35 Bn | 14.95 Bn | 1.29 Bn | 0.36 |
| 8 | Cooper Companies | 14.83 Bn | 14.69 Bn | 735.40 Mn | 0.20 |
| 9 | Baxter International | 13.53 Bn | 11.38 Bn | 1.03 Bn | 0.48 |
| 10 | Pulse Biosciences | 3.35 Bn | 3.35 Bn | 161,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 0.93 |
| Dec 31, 2022 | 0.83 |
| Sep 30, 2022 | 0.74 |
| Mar 31, 2021 | 0.51 |